ClinicalTrials.Veeva

Menu
C

Cleaver Medical Group Dermatology | Cumming, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tapinarof
Deuruxolitinib
SAR445399
Amlitelimab

Parent organization

This site is a part of Cleaver Medical Group Dermatology

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 4 total trials

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (CLAROS)

This is a multinational, randomized, double-blind, placebo-controlled, Phase 2, dose finding study to evaluate the efficacy and safety of different d...

Enrolling
Hidradenitis Suppurativa
Drug: SAR445399
Drug: Placebo

The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 2...

Enrolling
Atopic Dermatitis
Drug: Vehicle Cream
Drug: Tapinarof cream, 1%

This study evaluates the safety and effectiveness of deuruxolitinib in adolescents aged 12 to less than 18 years who have 50% or greater scalp hair l...

Enrolling
Alopecia Areata
Drug: Placebo
Drug: Deuruxolitinib

Trial sponsors

Sanofi logo
Organon logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems